Ovation Science Inc. OVAT
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -10.37% | -26.99% | -41.57% | -44.78% | -38.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.37% | -26.99% | -41.57% | -44.78% | -38.35% |
| Cost of Revenue | 332.61% | 268.52% | 0.00% | -71.19% | -83.86% |
| Gross Profit | -48.20% | -53.68% | -54.94% | -30.06% | -10.52% |
| SG&A Expenses | 37.95% | 22.83% | 13.54% | -28.37% | -33.42% |
| Depreciation & Amortization | -- | -- | -- | -100.00% | -83.33% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.20% | 25.17% | 10.08% | -28.76% | -34.88% |
| Operating Income | -48.99% | -36.01% | -22.28% | 25.73% | 34.35% |
| Income Before Tax | -43.32% | -53.40% | -34.50% | 36.96% | 31.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -43.32% | -53.40% | -34.50% | 36.96% | 31.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.32% | -53.40% | -34.50% | 36.96% | 31.86% |
| EBIT | -48.99% | -36.01% | -22.28% | 25.73% | 34.35% |
| EBITDA | 13.45% | -13.52% | -22.52% | 25.72% | 34.35% |
| EPS Basic | -36.17% | -44.71% | -28.28% | 39.72% | 38.56% |
| Normalized Basic EPS | -37.93% | -43.40% | -25.81% | 42.22% | 40.82% |
| EPS Diluted | -36.17% | -44.71% | -28.28% | 39.72% | 38.56% |
| Normalized Diluted EPS | -37.93% | -43.40% | -25.81% | 42.22% | 40.82% |
| Average Basic Shares Outstanding | 5.95% | 7.79% | 5.84% | 6.43% | 11.38% |
| Average Diluted Shares Outstanding | 5.95% | 7.79% | 5.84% | 6.43% | 11.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |